SEARCH

SEARCH BY CITATION

References

  • ABRAHAMSSON, T., BRANST, U., MARKLUND, S.L. & SJÖQVIST, P.-O. (1992). Vascular bound recombinant extracellular superoxide dismutase type C protects against detrimental effects of superoxide radicals on endothelium-dependent arterial relaxation. Circ. Res., 70, 264271.
  • AJI, W., RAVALLI, S., SZABOLCS, M., JIANG, X., SCIACCA, R.R., MICHLER, R.E. & CANNON, P.J. (1997). L-Arginine prevents xanthoma development and inhibits atherosclerosis in LDL receptor knockout mice. Circulation, 95, 430437.
  • BARTON, M., HAUDENSCHILD, C., D’USCIO, L., SHAW, S., MÜNTER, K. & LÜSCHER, T. (1998). Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc. Natl. Acad. Sci. U.S.A., 95, 1436714372.
  • BECKMAN, J.S. & KOPPENOL, W.H. (1996). Nitric oxide, superoxide and peroxynitrite: the good, the bad and the ugly. Am. J. Physiol., 271, C1424C1437.
  • BOSSALER, C., HABIB, G.B., YAMOMOTO, H., WILLIAMS, C. & WELLS, S. (1987). Impaired muscarinic endothelial-dependent relaxation and cyclic guanosine 5-monophosphate formation in atherosclerotic human coronary artery and rabbit aorta. J. Clin. Invest., 79, 170174.
  • BRAND, M.P., HEALES, S.J., LAND, J.M. & CLARK, J.B. (1995). Tetrahydrobiopterin deficiency and brain nitric oxide synthase in the hph1 mouse. J. Inherit. Metab. Dis., 18, 3339.
  • CALIGIURI, G., LEVY, B., PERNOW, J., THORÉN, P. & HANSSON, G. (1999). Myocardial infarction mediated by endothelin receptor signaling in hypercholesterolemic mice. Proc. Natl. Acad. Sci. U.S.A., 96, 69206924.
  • COSENTINO, F. & KATUSIC, Z. (1995). Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation, 91, 139144.
  • COSENTINO, F. & LÜSCHER, T.F. (1998). Tetrahydrobiopterin and endothelial function. Eur. Heart J., 19, (Suppl. G), G3G8.
  • COSENTINO, F., PATTON, S., D'USCIO, L.V., WERNER, E.R., WERNER-FELMYER, G., MOREAU, P., MALINSKI, T. & LŸSCHER, T.F. (1998). Tetrahydrobiopterin alters superoxide and nitric oxide release in prehypertensive rats. J. Clin. Invest., 101, 15301537.
  • CREAGER, M.A., GALLAGHER, S.J., GIRERD, X.J., COLEMAN, S.M., DZAU, V.J. & COOKE, J.P. (1992). L-Arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J. Clin. Invest., 90, 12481253.
  • DECKERT, V., LIZARD, G., DUVERGER, N., ATHIAS, A., PALLEAU, V., EMMANUEL, F., MOISANT, M., GAMBERT, P., LALLEMANT, C. & LAGROST, L. (1999). Impairment of endothelium-dependent arterial relaxation by high-fat feeding in apoE-deficient mice. Toward normalization by human apoA-I expression. Circulation, 100, 12301235.
  • DREXLER, H. (1997). Endothelial dysfunction: clinical implications. Prog. Cardiovasc. Dis., 39, 287324.
  • FONTANA, L., MCNEILL, K.L., RITTER, J.M. & CHOWIENCZYK, P.J. (1999). Effects of vitamin C and of a cell permeable superoxide dismutase mimietic on acute lipoprotein induced endothelial dysfunction in rabbit aortic rings. Br. J. Pharmacol., 126, 730734.
  • FÖRSTERMANN, U., MÜGGE, A., ACHEID, U., HAVERICH, A. & FRÖLICH, J.C. (1988). Selective attenuation of endothelial-mediated vasodilation atherosclerotic human coronary arteries. Circ. Res., 62, 185190.
  • FREIMAN, P.C., MITCHELL, G.C., HEISTAD, D.D., ARMSTRONG, M.L. & HARRISON, D.G. (1986). Atherosclerosis impairs endothelial-dependent vascular relaxation to acetylcholine and thrombin in primates. Circ. Res., 58, 783789.
  • IWASA, S., FAN, J., SHMOKAMA, T., NAGATA, M. & WATANABE, T. (1999). Increased immunoreactivity of endothelin-1 and endothelin B receptor in human atherosclerotic lesions. A possible role in atherogenesis. Atherosclerosis, 146, 93100.
  • JIANG, J., THORÉN, P., CALIGIURI, G., HANSSON, G.K. & PERNOW, J. (1999). Enhanced phenylephrine-induced rhythmic activity in the atherosclerotic mouse aorta via an increase in opening of KCa channels: relation to Kv channels and nitric oxide. Br. J. Pharmacol., 128, 637646.
  • KOLODGIE, F., VIRMANI, R., RICE, H.E. & MERGNER, W.J. (1990). Vascular reactivity during the progression of atherosclerotic plaque: a study in Watanabe heritable hyperlipidemic rabbits. Circ. Res., 66, 11121116.
  • KOWALA, M.C. (1997). The role of endothelin in the pathogenesis of atherosclerosis. Adv. Pharmacol., 37, 299318.
  • LÜSCHER, T.F. & NOLL, G. (1995). The pathogenesis of cardiovascular disease: role of the endothelium as target and mediator. Atherosclerosis, 188: (Suppl.) S81S90.
  • MARLETTA, M.A., HURSHMAN, A.R. & RUSCHE, K.M. (1998). Catalysis by nitric oxide synthase. Curr. Opin. Chem. Biol., 2, 656663.
  • MONCADA, S., PALMER, R.M.J. & HIGGS, E.A. (1991). Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev., 43, 109142.
  • NAKASHIMA, Y., PLUMP, A.S., RAINES, E.W., BRESLOW, J.L. & ROSS, R. (1994). ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb., 14, 133140.
  • PALMER, R.M., ASHTON, D.S. & MONCADA, S. (1988). Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature, 333, 664666.
  • PIEPER, G.M. (1997). Acute amelioration of diabetic endothelial dysfunction with a derivative of the nitric oxide synthase cofactor, tetrahydrobiopterin. J. Cardiovasc. Pharmacol., 29, 815.
  • PLUMP, A.S., SMITH, J.D., HAYEK, T., AALTO-SETÄLA, K., WALSH, A., VERSTUYFT, J.G., RUBIN, E.M. & BRESLOW, J.L. (1992). Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell, 71, 343353.
  • STROES, E., KASTELEIN, J., COSENTINO, F., ERKELENS, W., WEVER, R., KOOMANS, H., LÜSCHER, T. & RABELINK, T. (1997). Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. J. Clin. Invest., 99, 4146.
  • TIEFENBACHER, C.P., CHILIAN, W.M., MITCHELL, M. & DEFILY, D.V. (1996). Restoration of endothelium-dependent vasodilation after reperfusion injury by tetrahydrobiopterin. Circulation, 94, 14231429.
  • WERNER, E.R., WERNER-FELMAYER, G. & MAYER, B. (1998). Tetrahydrobiopterin, cytokines, and nitric oxide synthesis. Proc. Soc. Exp. Biol. Med., 219, 171182.
  • WEVER, R.M.F., LÜSCHER, T.F., COSENTINO, F. & RABELINK, T.J. (1998). Atherosclerosis and the two faces and endothelial nitric oxide synthase. Circulation, 97, 108112.
  • YANAGISAWA, M., KURIHARA, H., KIMURA, S., TOMOBE, Y., KOBAYASHI, M., MITSUI, Y., YAZAKI, Y., GOTO, K. & MASAKI, T. (1988). A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature, 332, 411415.
  • ZEIHER, A.M., DREXLER, H., WOLLSCHLÄGER, H. & JUST, H. (1991). Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation, 84, 19841992.
  • ZHANG, S.H., REDDICK, R.L., PIEDRAHITA, J.A. & MAEDA, N. (1992). Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science, 258, 468471.